During the past decade, Osaka University, Graduate School of Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka University, Graduate School of Medicine" #1 sponsor was "Kansai Hepatobiliary Oncology Group" with 6 trials, followed by "Haruhiko Fukuda" with 3 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Nobelpharma" with 2 trials sponsored and "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka University, Graduate School of Medicine" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Japan Clinical Oncology Group" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator, "Kurosawa Hospital" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Osaka University, Graduate School of Medicine" are "Biliary Tract Cancer" (4 trials), "Angiofibroma" (2 trials), "Hypomelanotic Macule" (2 trials), "Plaque" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Osaka University, Graduate School of Medicine" in a lesser frequency.

Most popular intervention types in "Osaka University, Graduate School of Medicine" are "Drug" (15 trials), "Radiation" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "NPC-12G gel" (2 trials), "S-1" (2 trials), "cyclophosphamide" (2 trials) and "dactinomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Osaka University, Graduate School of Medicine" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Osaka University, Graduate School of Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Osaka University, Graduate School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka University, Graduate School of Medicine, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".